514 related articles for article (PubMed ID: 26229440)
1. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
2. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
4. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI
Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656
[TBL] [Abstract][Full Text] [Related]
5. Dual Functional Eudragit
Gao C; Yu S; Zhang X; Dang Y; Han DD; Liu X; Han J; Hui M
Int J Nanomedicine; 2021; 16():1405-1422. PubMed ID: 33658780
[TBL] [Abstract][Full Text] [Related]
6. pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions.
Naeem M; Oshi MA; Kim J; Lee J; Cao J; Nurhasni H; Im E; Jung Y; Yoo JW
Nanomedicine; 2018 Apr; 14(3):823-834. PubMed ID: 29353017
[TBL] [Abstract][Full Text] [Related]
7. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
8. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
Oshi MA; Naeem M; Bae J; Kim J; Lee J; Hasan N; Kim W; Im E; Jung Y; Yoo JW
Carbohydr Polym; 2018 Oct; 198():434-442. PubMed ID: 30093020
[TBL] [Abstract][Full Text] [Related]
9. Enzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon.
Naeem M; Kim W; Cao J; Jung Y; Yoo JW
Colloids Surf B Biointerfaces; 2014 Nov; 123():271-8. PubMed ID: 25266978
[TBL] [Abstract][Full Text] [Related]
10. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
[TBL] [Abstract][Full Text] [Related]
11. Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles.
Naeem M; Cao J; Choi M; Kim WS; Moon HR; Lee BL; Kim MS; Jung Y; Yoo JW
Int J Nanomedicine; 2015; 10():4565-80. PubMed ID: 26213469
[TBL] [Abstract][Full Text] [Related]
12. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM
Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953
[TBL] [Abstract][Full Text] [Related]
13. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases.
Ali H; Weigmann B; Neurath MF; Collnot EM; Windbergs M; Lehr CM
J Control Release; 2014 Jun; 183():167-77. PubMed ID: 24685705
[TBL] [Abstract][Full Text] [Related]
14. Micro- and Nanoencapsulated Hybrid Delivery System (MNEHDS): A Novel Approach for Colon-Targeted Oral Delivery of Berberine.
Zhang L; Li M; Zhang G; Gao C; Wang S; Zhang T; Ma C; Wang L; Zhu Q
Mol Pharm; 2021 Apr; 18(4):1573-1581. PubMed ID: 33629860
[TBL] [Abstract][Full Text] [Related]
15. Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitis.
Crcarevska MS; Dodov MG; Petrusevska G; Gjorgoski I; Goracinova K
J Drug Target; 2009 Dec; 17(10):788-802. PubMed ID: 19938950
[TBL] [Abstract][Full Text] [Related]
16. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
[TBL] [Abstract][Full Text] [Related]
17. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis.
Patel NV; Patel JK; Shah SH; Patel JN
Pharmazie; 2011 Feb; 66(2):124-9. PubMed ID: 21434575
[TBL] [Abstract][Full Text] [Related]
18. Budesonide-Loaded Eudragit S 100 Nanocapsules for the Treatment of Acetic Acid-Induced Colitis in Animal Model.
Qelliny MR; Aly UF; Elgarhy OH; Khaled KA
AAPS PharmSciTech; 2019 Jun; 20(6):237. PubMed ID: 31243601
[TBL] [Abstract][Full Text] [Related]
19. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis.
Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW
Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207
[TBL] [Abstract][Full Text] [Related]
20. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
